CanSino Biologics Inc (CJH) — Cash Flow Reinvestment Rate

Latest as of December 2021: 0.43x

CanSino Biologics Inc (CJH) has a Cash Flow Reinvestment Rate of 0.43x as of December 2021, reinvesting €344.15 Million (capex €284.07 Million plus investments €-60.09 Million) from operating cash flow of €806.73 Million. Check CanSino Biologics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.43x
(Capex + Investments) / Operating CF

Total Reinvested

€344.15 Million
Capex + Investments

Operating Cash Flow

€806.73 Million
EUR

Capital Expenditures

€284.07 Million
EUR

CanSino Biologics Inc Cash Flow Reinvestment Rate (2021–2025)

Historical reinvestment intensity for CanSino Biologics Inc across 2 annual periods. Explore CanSino Biologics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for CanSino Biologics Inc (2021–2025)

Year-by-year capital reinvestment analysis for CanSino Biologics Inc. For live market cap and broader valuation context, see market cap of CanSino Biologics Inc.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 10.78x €839.60 Million €77.86 Million €243.90 Million ▲ +748.3%
2021 1.27x €2.61 Billion €2.05 Billion €1.20 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow